Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- AVE.AU
- Price
- 0.01
- Stock movement up
- +- (0.00%)
- Company name
- Avecho Biotechnology Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 36.73M
- Ent value
- 37.17M
- Price/Sales
- 25.51
- Price/Book
- 44.52
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 150.00%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-15
DIVIDENDS
AVE.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 25.51 |
| Price to Book | 44.52 |
| EV to Sales | 25.81 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.67B |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.93M |
| Net receivables | 895.31K |
| Total current assets | 7.07M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 7.19M |
| Accounts payable | 660.98K |
| Short/Current long term debt | 57.12K |
| Total current liabilities | 1.53M |
| Total liabilities | 6.37M |
| Shareholder's equity | 825.16K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.01 |
| Daily high | 0.01 |
| Daily low | 0.01 |
| Daily Volume | 13.9M |
| All-time high | 0.87 |
| 1y analyst estimate | 1.72 |
| Beta | 1.48 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 22 Sep 2010 |
| Next earnings date | 28 Jan 2026 |
Downside potential
Loading...
Downside potential data
| AVE.AU | S&P500 | |
| Current price drop from All-time high | -98.85% | -1.22% |
| Highest price drop | -99.77% | -19.00% |
| Date of highest drop | 13 Jan 2025 | 8 Apr 2025 |
| Avg drop from high | -99.44% | -2.64% |
| Avg time to new high | - | 6 days |
| Max time to new high | 293 days | 89 days |
COMPANY DETAILS
Marketcap
36.73M
Marketcap category
Small-cap
Description
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found